Research map: PSMA PET in Prostate Cancer: Clinical Value, Access Challenges, and Priorities for Implementation
Back to the article
Papers in this map
Using PSMA imaging for prognostication in localized and advanced prostate cancer
· Matthew J. Roberts · 2022 · 90 citations · Cited by this paper
Editorial: Recent advances in theranostics: endocrine tumours and beyond
· Alberto Nieri · 2026 · Cites this paper
Oncological Outcomes of Different Managements of the Distal Ureter in Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma
· 2026 · Related
A Comprehensive Systematic Review and Meta-analysis of the Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Diagnosis and Primary Staging before Definitive Treatment
· Elio Mazzone · 2025 · 58 citations · Cited by this paper
Prognostic Factors for Recurrence and Survival After Radical Cystectomy for Non–muscle-invasive Bladder Cancer: A Multicenter Analysis of 1032 Patients
· 2026 · Related
The Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Assessment of Local Recurrence and Distant Metastases in Patients with Biochemical Recurrence of Prostate Cancer After Definitive Treatment: A Systematic Review and Meta-analysis
· Elio Mazzone · 2025 · 38 citations · Cited by this paper
When Patients Refuse Radical Cystectomy: Integrating Trimodality Therapy in the Perioperative ICI/ADC Era
· 2026 · Related
Disparities in PET Imaging for Prostate Cancer at a Tertiary Academic Medical Center
· Matthew D. Bucknor · 2020 · 30 citations · Cited by this paper
Doublet Versus Triplet Therapy in High-volume Metastatic Hormone-sensitive Prostate Cancer Patients with Bone Metastases: Results from the ARON-3 Study
· 2026 · Related
More Accurate Imaging Is Not Stage Migration: Time To Move from “Hubble” to “Webb” in Hormone-sensitive Prostate Cancer
· Narjess Ayati · 2022 · 13 citations · Cited by this paper
Individual Patient Data Validation of the EAU Definitions of BCG Failure in Patients with Non–muscle-invasive Urothelial Carcinoma of the Bladder: An International Multicenter Retrospective Study
· 2026 · Related
PET imaging utilization and trends in Germany: a comprehensive survey
· Adrien Holzgreve · 2025 · 11 citations · Cited by this paper
Salvage High-intensity Focused Ultrasound for Prostate Cancer Recurrence after Radiotherapy (HIFI-2 Study)
· 2026 · Related
Modern Imaging in Prostate Cancer: Do We Treat Patients, or Their Scans?
· Malcolm David Mason · 2022 · 9 citations · Cited by this paper
PI-RADS v2 and Adverse Prostate Cancer Outcomes: A Cross-cohort Replication Study Across Three Centers
· 2026 · Related
How Does Routine Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Modify the Current Management of Prostate Cancer? A Multidisciplinary View
· Daniela E. Oprea‐Lager · 2025 · 7 citations · Cited by this paper
Study Protocol of OLIGOPELVIS 2–GETUG P12: A Randomized Phase 3 Study Comparing Intermittent Androgen-deprivation Therapy with or Without Salvage High-dose Intensity-modulated Radiotherapy to Oligorecurrent Pelvic and Para-aortic Lymph Nodes in Patients with Biochemically Relapsing Prostate Cancer
· 2026 · Related
Utilization of prostate-specific membrane antigen positron emission tomography in Australia following government subsidization: Trends in primary staging and biochemical recurrence.
· Kieran Sandhu · 2025 · 4 citations · Cited by this paper
Outcomes of Intermediate Risk Non–muscle-invasive Bladder Cancer Receiving Adjuvant Treatment: A Pooled Analysis of Four Randomized Controlled Trials
· 2026 · Related
Association of marginalization and PSMA-PET in prostate cancer
· Vivian S. Tan · 2025 · 2 citations · Cited by this paper
The Diagnostic Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Patients with Rising PSA After Radical Prostatectomy and Postoperative Radiotherapy: A Systematic Review and Meta-analysis
· Donato Cannoletta · 2026 · 1 citation · Cited by this paper
Source: OpenAlex (CC0)